Briumvi is used to treat relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease, in adults.
The medication is a non-steroidal anti-inflammatory drug indicated for the acute treatment of migraine attacks with or without aura, in adults 18 years of age or older.